Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02061761 |
| Title | Safety Study of Anti-LAG-3 in Relapsed or Refractory Hematologic Malignancies |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Bristol-Myers Squibb |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Local Institution - 0007 | Baltimore | Maryland | 21205 | United States | Details | |
| Local Institution - 0004 | Boston | Massachusetts | 02215 | United States | Details | |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
| Local Institution - 0010 | Saint Louis | Missouri | 63110 | United States | Details | |
| Weill Cornell Medical College | New York | New York | 10021 | United States | Details | |
| Local Institution - 0002 | Portland | Oregon | 97239 | United States | Details | |
| Local Institution - 0006 | Houston | Texas | 77030 | United States | Details | |
| Local Institution - 0001 | Seattle | Washington | 98109 | United States | Details | |
| Local Institution - 0011 | Vancouver | British Columbia | V5Z 4E6 | Canada | Details | |
| Local Institution - 0012 | Toronto | Ontario | M5G 2M9 | Canada | Details |